Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026)
Aquestive Therapeutics (AQST) recorded Gross Margin of 70.93% in Q2 2026, up 16.53 percentage points from 54.40% a year earlier but down 5.06 percentage points from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Aquestive Therapeutics' Gross Margin came in at 67.04% as of Jun 30, 2026, up 5.94 percentage points year-over-year; for FY2025, it was 58.35%, down 10.61 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -13.38 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 68.95% in FY2024 (+10.13 pp), 58.82% in FY2023 (-0.52 pp), 59.34% in FY2022 (-11.17 pp) and 70.51% in FY2021 (-1.21 pp).
- Quarterly Gross Margin has ranged from 50.03% in Q2 2023 to 77.48% in Q2 2024 over the past five years.
- On a year-over-year basis, Gross Margin rose in three of the last eight quarters, with an average year-over-year change of -0.23 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 27.46 percentage points in Q2 2024, against a drop of 23.08 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 75.99% (Q1 2026), 55.16% (Q4 2025) and 64.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Aquestive Therapeutics | 596.18 Mn | 136.72 Mn | 9.80 Mn | 70.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.93% |
| Mar 31, 2026 | 75.99% |
| Dec 31, 2025 | 55.16% |
| Sep 30, 2025 | 64.82% |
| Jun 30, 2025 | 54.40% |
| Mar 31, 2025 | 58.12% |
| Dec 31, 2024 | 61.91% |
| Sep 30, 2024 | 67.24% |
| Jun 30, 2024 | 77.48% |
| Mar 31, 2024 | 63.59% |
| Dec 31, 2023 | 64.57% |
| Sep 30, 2023 | 63.10% |
| Jun 30, 2023 | 50.03% |
| Mar 31, 2023 | 57.45% |
| Dec 31, 2022 | 50.34% |
| Sep 30, 2022 | 59.65% |
| Jun 30, 2022 | 60.48% |
| Mar 31, 2022 | 65.66% |
| Dec 31, 2021 | 69.62% |
| Sep 30, 2021 | 66.88% |
API Access
Aquestive Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();